Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Madan, Jagmeet
- High Fructose Intake, HCFS and Metabolic Syndrome-Should We Be On Guard?
Abstract Views :236 |
PDF Views:4
Authors
Affiliations
1 Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
2 Nirmala Niketan College of Home Science, Mumbai University, IN
1 Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
2 Nirmala Niketan College of Home Science, Mumbai University, IN
Source
The Indian Practitioner, Vol 71, No 10 (2018), Pagination: 7-10Abstract
The prevalence of Non-Communicable Diseases (NCDs) is increasing universally at an alarming rate. NCDs are estimated to account for 60% of total deaths. Globally, type 2 diabetes mellitus is prevalent in epidemic proportions. According to International Diabetes Federation (IDF), 366 million adults were affected by the disease in 2011, and this figure is likely to escalate to 552 million by 2030. India, like many other developing countries, faces the triple burden of malnutrition from the persisting array of communicable diseases, lifestyle related NCDs and micronutrient deficiencies. This cuts across all age groups and socioeconomic strata.
References
- Hosseini-Esfahani F, Hosseinpanah F, Azizi F, Hosseinpour-Niazi S, Bahadoran Z, Mirmiran P: Dietary fructose and risk of metabolic syndrome in adults: Tehran Lipid and Glucose study [electronic resource]. Nutrition & Metabolism 2011, 8.
- Tappy L, Lê K-A: Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews 2010a, 90:23-46.
- Malik VS, Hu FB. Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar- Sweetened Beverages. Curr Diab Rep (2012) 12:195-203 DOI 10.1007/s11892-0120259-6.
- Hanover LM, White JS. Manufacturing, composition and applications of fructose. Am J Clin Nutr. 1993;58:724S–32S.
- Vuilleumier S. Worldwide production of high-fructose syrup and crystalline fructose. Am J Clin Nutr.
- ;58:733S–6S.
- Park YK, Yetley EA. Intake and food sources of fructose in the United States. Am J Clin Nutr. 1993;58:737S–47S.
- Sigman-Grant M, Keast DR. Addendum to Am J ClinNutr 1995;62 (Suppl):178S–194S. Am J Clin Nutr. 1997;65:1572– 4.
- Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake of macronutrients, micronutrients and other dietary constituents: United States 1988–94. National Center for Health Statistics. Vital Health Stat 11. 2002;245:1–58.
- Popkin BM, Nielsen SJ. The sweetening of the world’s diet. Obes Res. 2003;11:1325–32.
- Chan T-F, Lin W-T, Chen Y-L, Huang H-L, Yang W-Z, Lee C-C, Chen M-H, Wang T-N, Huang M-C, et al.
- Elevate Serum Triglyceride and Retinal-Binding Protein 4 Levels Associated with Fructose-Sweetened Beverages in Adolescents. PLOS. 2014;9:1-9.
- Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W.; et al. Consuming fructosesweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322–1334.
- Jensen, M.D.; Haymond, M.W.; Rizza, R.A.; Cryer, P.E.; Miles, J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Investig. 1989, 83, 1168–1173.
- Ma J, Sloan M, Fox CS, Hoffmann U, Smith CE, Saltzman E, Rogers GT, Jacques PF, McKeown NM Sugar-sweetened beverage consumption is associated with abdominal fat partitioning in healthy adults. J Nutr 2014;144:1283–90.
- Sievenpiper, J.L.; de Souza, R.J.; Mirrahimi, A.; Yu, M.E.; Carleton, A.J.; Beyene, J.; Chiavaroli, L.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-analysis. Ann. Intern. Med. 2012, 156, 291–304.
- Perry, R.J.; Camporez, J.P.; Kursawe, R.; Titchenell, P.M.; Zhang, D.; Perry, C.J.; Jurczak, M.J.; Abudukadier, A.; Han, M.S.; Zhang, X.M.; et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015, 160, 745–758.
- David Wang, D.; Sievenpiper, J.L.; de Souza, R.J.; Cozma, A.I.; Chiavaroli, L.; Ha, V.; Mirrahimi, A.; Carleton, A.J.; Di Buono, M.; Jenkins, A.L.; et al. Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014, 232, 125–133.
- Agebratt, C.; Strom, E.; Romu, T.; Dahlqvist-Leinhard, O.; Borga, M.; Leandersson, P.; Nystrom, F.H. A randomized study of the effects of additional fruit and nuts consumption on hepatic fat content, cardiovascular risk factors and basal metabolic rate. PLoS ONE 2016, 11, e0147149.
- Marriott,B.P.; Cole,N.; Lee, E. National estimates of dietary fructose intake increased from1977 to 2004 in the United States. J. Nutr. 2009, 139, 1228s–1235s.
- Chung,M.; Ma,J.; Patel,K.; Berger,S.; Lau,J.; Lichtenstein, A.H. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2014, 100, 833–849.
- TeMorenga,L.; Mallard,S.; Mann, J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012, 346, e7492.
- Chiu,S.; Sievenpiper,J.L.; deSouza,R.J.; Cozma,A.I.; Mirrahimi,A.; Carleton,A.J.; Ha,V.; DiBuono,M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials. Eur. J. Clin. Nutr. 2014, 68, 416–423.
- Volynets,V.; Machann,J.; Kuper,M.A.; Maier,I.B.; Spruss,A.; Konigsrainer,A.; Bischoff,S.C.; Bergheim,I. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): A pilot study. Eur. J. Nutr. 2013, 52, 527–535.
- Schwarz,J.M.; Noworolski,S.M.; ErkinCakmak,A.; Korn,N.J.; Wen,M.J.; Tai,V.W.; Jones,G.M.; Palii,S.P.; Velasco-Alin, M.; Pan, K.; et al. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology 2017.
- Kelishadi R, Mansourian M, Heidari-Beni M. Association of fructose consumption and components of metabolic syndrome in human studies: A systematic review and meta-analysis. Nutrition. 2014;30:503–10.
- Bantle, J. P. Dietary fructose and metabolic syndrome and diabetes. J. Nutr.139, 1263S–1268S (2009).
- Shin JY, Kim JY, Kang HT, Han KH, Shim JY. Effect of fruits and vegetables on metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Int J Food Sci Nutr. 2015;66(4):416–25.PubMed.
- Dushay JR, Toschi E, Mitten EK, Fisher FM, Herman MA, Maratos-Flier E.Fructose ingestion acutely stimulates circulating FGF21 levels in humans. MolMetab. 2014 Oct 8;4(1):51-7. doi: 10.1016/j.molmet.2014.09.008. eCollection 2015 Jan.
- Bone Mineral Density of Post-Menopausal Diabetic and Non-Diabetic Women from Mumbai City
Abstract Views :268 |
PDF Views:0
Authors
Affiliations
1 Department of Food Nutrition and Dietetics, Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
2 Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
3 Department Nutrition Research and Biostatistics, NutriCanvas, Mumbai, IN
4 Department of Imaging Nanavati Super speciality Hospital, Mumbai, IN
1 Department of Food Nutrition and Dietetics, Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
2 Sir Vithaldas Thackersey College of Home Science (Autonomous), SNDT Women’s University, Mumbai, IN
3 Department Nutrition Research and Biostatistics, NutriCanvas, Mumbai, IN
4 Department of Imaging Nanavati Super speciality Hospital, Mumbai, IN
Source
The Indian Practitioner, Vol 73, No 6 (2020), Pagination: 20-25Abstract
Objective: To assess the bone mineral density of type 1 and type 2 diabetic and non-diabetic post-menopausal women.
Methods: A cross-sectional study was conducted in 98 post-menopausal women aged 60.5±6.4 years. The participants comprised of 20 type 1 diabetics, 28 type 2 diabetic women and 50 non diabetic women. Anthropometry and dietary intake was assessed for all participants. T score for bone mineral density was measured by DEXA at lumbar spine, femoral neck and total body. This was used to classify women as suffering from osteoporosis and osteopenia.
Results: The mean weight was significantly higher in type 1 and type 2 diabetics as compared to non-diabetics (p<0.05). Protein and calcium intake was 52-60% of the RDA in diabetics. There was no significant difference in T score at lumbar spine, femoral neck or total body between the 3 groups (p>0.05). After adjusting for weight and nutri-ent intake, lumbar spine and femoral neck T score was significantly lower in type 1 diabetics (p<0.05). Type 2 diabetics also had significantly lower adjusted femoral neck T score as compared to non-diabetics (p<0.05). Higher percentage of type 2 diabetics (77.8%) and non-diabetics (77.5%) had low bone density (osteopenia + osteoporosis) at lumbar spine as compared to type 1 diabetics (60%). Higher percentage of type 1 diabetics (75%) and type 2 diabetics (82.1%) had low bone density at femoral neck.
Conclusion: A high percentage of postmenopausal women in Mumbai were observed to be osteopenic and osteopo-rotic. Dietary and lifestyle Intervention programs need to be developed to prevent onset of osteopenia and osteoporo-sis especially in diabetic post-menopausal women.
Keywords
Osteoporosis, Osteopenia, Type 1 Diabetes, Type 2 Diabetes, T Score, Dietary Intake.References
- J MXi, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med. 2015;1(1):9–13.
- Consensus development conference: Diagnosis, prophylax-is, and treatment of osteoporosis. Am J Med. 1993;94(6):646– 50.
- Bonjour JP, Chevalley T, Ferrari S, Rizzoli R. The importance and relevance of peak bone mass in the prevalence of osteo-porosis. Salud Publica Mex. 2009; 51 Suppl 1:S5-17.
- Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006Feb;194(2 Suppl):S3-11 5. Pai M V. Osteoporosis Prevention and Management. J Obstet Gynecol India. 2017;67(4):237–42.
- Alswat KA. Gender Disparities in Osteoporosis. J Clin Med Res. 2017;9(5):382–7.
- Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243–51.
- Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; IOF CSA Working Group on Fracture Epidemiology. Secular trends in the incidence of hip and other osteoporotic fractures. Vol. 22, Osteoporosis International. Osteoporos Int; 2011. p.1277– 88.
- Khadilkar AV, Mandlik RM. Epidemiology and treatment of osteoporosis in women: An Indian perspective. Osteoporos Int. 2011May;22(5):1277-88
- Jackuliak P, Payer J. Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2014; 2014:820615.
- Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - A meta-analysis. Osteoporos Int. 2007Apr;18(4):427–44.
- Dhaon P, Shah V. Type 1 diabetes and osteoporosis: A re-view of literature. Indian J Endocrinol Metab. 2014;18(2):159.
- Leidig-Bruckner G, Grobholz S, Bruckner T, Scheidt-Nave C, Nawroth P, Schneider JG. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord. 2014Apr 11;14(1):33.
- Paschou SAΑ, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. J Clin Endocrinol Metab. 2017;102(10):3621–34.
- Karimifar M, Pasha MAP, Salari A, Zamani A, Salesi M, Motaghi P. Evaluation of bone loss in diabetic postmeno-pausal women. J Res Med Sci. 2012;17(11):1033–8.
- Neglia C, Agnello N, Argentiero A, Chitano G, Quarta G, Bortone I, Della Rosa G, Caretto A, Distante A, Colao A, Di Somma C, Migliore A, Auriemma RS, Piscitelli P. Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a three-year longitudinal study with pha-langeal QUS measurements. J Biol Regul Homeost Agents. 2014;28(4):733–41.
- WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.
- Meeta, Harinarayan CV, Marwah R, Sahay R, Kalra S BS. Clinical practice guidelines on postmenopausal osteoporo-sis: An executive summary and recommendations. J Midlife Health. 2013;4(2):107–26.
- Gopalan C, Ramasastri BB, Balasubramanyam SC. Nutritive Value of Indian Foods. National Institute of Nutrition, Indian Council of Medical Research, Hyderabad, India; 2003.
- A report of the expert group of the Indian Council of Medical Research, Nutrient requirement and recommended dietary allowances for Indians. 2009. Available from: http://icmr.nic.in/final/RDA-2010.pdf. [Assessed on 1st May 2020].
- Fellinger P, Fuchs D, Wolf P, Heinze G, Luger A, Krebs M, Winhofer Y. Overweight and obesity in type 1 diabetes equal those of the general population. Wien Klin Wochenschr. 2019 Feb 1;131(3–4):55–60.
- Sharma S, Tandon VR, Mahajan A, Kour A, Kumar D. Preliminary screening of osteoporosis and osteopenia in ur-ban women from Jammu using calcaneal QUS. Indian J Med Sci. 2006;60(5):183–9.
- Marwaha RK, Tandon N, Garg MK, Kanwar R, Narang A, Sastry A, Saberwal A, Bhadra K, Mithal A. Bone health in healthy Indian population aged 50 years and above. Osteoporos Int. 2011;22(11):2829–36.
- Kadam N, Chiplonkar S, Khadilkar A, Divate U, Khadilkar V. Low bone mass in urban Indian women above 40 years of age: Prevalence and risk factors. Gynecol Endocrinol. 2010;26(12):909–17.
- Sharma, Singh H, Chodhary P, Saran S, Mathur SK. Osteoporosis in otherwise healthy patients with type 2 diabetes: A prospective gender based comparative study. Indian J Endocrinol Metab. 2017;21(4):535.
- Prakash S, Jatti RS, Ghagane SC, Jali SM, Jali M V. Prevalence of osteoporosis in type 2 diabetes mellitus patients using dual energy X-ray absorptiometry (DEXA) scan. Int J Osteoporos Metab Disord. 2017;10(2):10–6.
- Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between obesity and bone mineral density and vertebral frac-tures in Korean postmenopausal women. Yonsei Med J. 2010;51(6):857–63.
- Gonnelli S, Caffarelli C, Nuti R. Obesity and fracture risk. Clin Cases Miner Bone Metab. 2014;11(1):9.
- Harinarayan C V, Ramalakshmi T. Patterns of dietary calcium intake in south Indian rural, urban and metropolitan city subjects. J Clin Scien Res. 2015;4(5):143-148
- Heaney Robert P. Protein and Calcium: Antagonists or Synergists? Am J Clin Nutr . 2002;74(4):609–10.
- Bonjour JP. Dietary Protein: An Essential Nutrient For Bone Health. J Am Coll Nutr. 2005;1;24:526S-536S.
- Medical Nutrition Therapy for Management of COVID 19 for Adults – Compiled Guidelines by the Indian Dietetic Association (2019-2022)
Abstract Views :132 |
PDF Views:0
Authors
Jagmeet Madan
1,
Vibha Hasija
2,
Anuja Agarwala
3,
Madhu Sharma
4,
Naaznin Husein
5,
Sheryl Salis
6,
Kavita Bakshi
7,
Shilpa Shirole
8,
Eileen Canday
9
Affiliations
1 Principal, Sir Vithaldas Thackersey College of Home Science (Autonomous) SNDT Women’s University, Mumbai, IN
2 Registered Dietitian, Assistant Professor, College of Home -Science Nirmala Niketan, Mumbai., IN
3 Former Senior Dietician, AIIMS, New Delhi, IN
4 Former Senior Dietician, PGI, Chandigarh, IN
5 Founder Director, Freedom, Mumbai, IN
6 RD, CDE, Chief Dietitian and Founder Director, Nurture Health Solutions, Mumbai, IN
7 Faculty, Nagpur, IN
8 Consultant Nutritionist, Pune, IN
9 Chief Dietitian, HN Reliance Foundation Hospital, Mumbai, IN
1 Principal, Sir Vithaldas Thackersey College of Home Science (Autonomous) SNDT Women’s University, Mumbai, IN
2 Registered Dietitian, Assistant Professor, College of Home -Science Nirmala Niketan, Mumbai., IN
3 Former Senior Dietician, AIIMS, New Delhi, IN
4 Former Senior Dietician, PGI, Chandigarh, IN
5 Founder Director, Freedom, Mumbai, IN
6 RD, CDE, Chief Dietitian and Founder Director, Nurture Health Solutions, Mumbai, IN
7 Faculty, Nagpur, IN
8 Consultant Nutritionist, Pune, IN
9 Chief Dietitian, HN Reliance Foundation Hospital, Mumbai, IN
Source
The Indian Practitioner, Vol 75, No 7 (2022), Pagination: 7-12Abstract
The advent of COVID-19 waves has continued since 2020, and we are here to accept that as individuals we have to learn to combat and recover from this infection effectively by COVID appropriate behaviour of quarantine, complete schedules of vaccination, masking, hand washing and a good dietary intervention to enable good recovery. This compiled review from the working group of Nutritionist of Indian Dietetic Association (2019-2022) will serve as a ready reference for dietitians, physicians and healthcare professionals in different settings; to advise the right diet and adequate nutrition for the adult COVID patients in different stages of the infection.The key points include- in mild intensity disease, while the patient is quarantined and home bound, the emphasis is on consuming adequate nutrient dense foods supporting the immune system, as well as providing adequate hydration. The role of traditional practices and immune boosting nutrients will also help in supporting the mildly affected patient. In case of moderate illness, the demand consequent to running fever and cough needs to be met. The needs of the elderly population and patients with co-morbidities would be very specific and critical, and that needs to be thoroughly monitored. The management of a patient with critical illness, needing intensive care support, will need customized parenteral and enteral nutrition support. The dietary specifications in case of co-morbidities, for those needing ventilator support and ECHMO have been enumerated. This paper clearly brings out the need for an individualized nutrition support delivered by a qualified Nutritionist as a part of health care team in each of the stages of the COVID-19 infection, and is a strong recommendation.Keywords
COVID 19, Medical Nutrition Therapy, Adults, Mild, Moderate, Acute Respiratory DistressReferences
- World Health Organization. Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection is Suspected [Internet]. World Health Organization; 2020 p. 1-10. Available from: https://apps.who.int/iris/handle/10665/330893
- Mishra, S., Sharma, D., Raghuvanshi, A., Rajput, A., Chaturvedi, V., & Shanno, K. Potential impact of nutrition on immune system: prevent or assist covid-19 recovery. Journal of Advances in Medicine and Medical Research. 2020. 32(22), 20-33.
- Yeoh YK, Zuo T, Lui GC, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021;70:698-706
- Liang T, Yu L. Handbook of COVID-19 Prevention and Treatment. Zhejiang University School of Medicine; 2020.
- Fernández-Quintela, A., Milton-Laskibar, I., Trepiana, J., Gómez-Zorita, S., Kajarabille, N., Léniz, A., González, M., & Portillo, M. P. Key aspects in nutritional management of Covid-19 patients. Journal of clinical medicine. 2020. 9(8), 2589.
- Sutaria, Muskaan &Keny, Greeshma&Pratinidhi, Shilpa. COVID-19 and its effect on nutrition. International Journal of Community Medicine and Public Health. 2020. 7. 4112.
- Formisano E, Di Maio P, Ivaldi C, Sferrazzo E, Arieta L, Bongiovanni S, Panizzi L, Valentino E, Pasta A, Giudice M, Demontis S. Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nutrition. 2021 Feb;82:111048.
- Martindale R, Patel J, Taylor B, Warren M, McClave S. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care [Internet]. Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN); 2020. Available from: https://www.sccm.org/COVID19RapidResources/Resources/Nutrition-Therapy-in-the-Patient-with-COVID-19-Dis
- Singer P. Nutritional and metabolic management of Covid -19 intensive care patients, the ESPEN Council, Espen expert statements and practical guidance for nutritional management of COVID 19. 2020.
- Singer P, Blaser A, Berger M, Alhazzani W, Calder P, Casaer M et al. ESPEN Guideline on Clinical Nutrition in the Intensive Care Unit. Clinical Nutrition. 2019;38(1):48-79.
- Ferrara, F., De Rosa, F. &Vitiello, A. The Central Role of Clinical Nutrition in COVID-19 Patients during and After Hospitalization in Intensive Care Unit. SN Comprehensive Clinical Medicine. 2020. 2, 1064–1068.